✦ LIBER ✦

Evaluation of the Long-Term Tolerability and Clinical Benefit of Vorinostat in Patients With Advanced Cutaneous T-Cell Lymphoma

✍ Scribed by Duvic, Madeleine; Olsen, Elise A.; Breneman, Debra; Pacheco, Theresa R.; Parker, Sareeta; Vonderheid, Eric C.; Abuav, Rachel; Ricker, Justin L.; Rizvi, Syed; Chen, Cong; Boileau, Kathleen; Gunchenko, Alexandra; Sanz-Rodriguez, Cesar; Geskin, Larisa J.

Book ID: 119936146
Publisher: CIG Media Group, LP.
Year: 2009
Tongue: English
Weight: 201 KB
Volume: 9
Category: Article
ISSN: 1557-9190
DOI: 10.3816/clm.2009.n.082

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term outcome of patients with advan

Long-term outcome of patients with advanced-stage cutaneous T cell lymphoma treated with gemcitabine

✍ Pellegrini, Cinzia; Stefoni, Vittorio; Casadei, Beatrice; Maglie, Roberto; Argna 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 202 KB

Clinical and laboratory experience of vo

Clinical and laboratory experience of vorinostat (suberoylanilide hydroxamic acid) in the treatment of cutaneous T-cell lymphoma

✍ Duvic, M; Zhang, C 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 119 KB

Long-term follow-up and survival of cuta

Long-term follow-up and survival of cutaneous T-cell lymphoma patients treated with extracorporeal photopheresis

✍ Robert Knobler; Madeleine Duvic; Christiane Querfeld; David Straus; Steven Horwi 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

Long-term implications of T-cell recepto

Long-term implications of T-cell receptor gene rearrangement analysis by Southern blot in patients with cutaneous T-cell lymphoma

✍ Joan Guitart; Charles Camisa; Michelle Ehrlich; Wilma F. Bergfeld 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Role of interferon alfa-2b in the manage

Role of interferon alfa-2b in the management of patients with advanced cutaneous T-cell lymphoma

✍ Tariq I. Mughal 📂 Article 📅 1991 🏛 Elsevier Science ⚖ 232 KB

Phase I and pharmacokinetic study of the

Phase I and pharmacokinetic study of the oral histone deacetylase inhibitor vorinostat in Japanese patients with relapsed or refractory cutaneous T-cell lymphoma

✍ Hidefumi WADA; Ryoji TSUBOI; Yukihiko KATO; Makoto SUGAYA; Kensei TOBINAI; Toshi 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 French ⚖ 236 KB